I am a highly collaborative, adaptable, and decisive executive and scientist with 10+ years of progressive leadership experience directing ligand binding assay method development, validation, and sample analysis supporting pharmacokinetic, immunogenicity, and regulated biomarker analysis in addition to pre-clinical and clinical studies from candidate selection through post-marketing including Phase I-III clinical studies. As a resourceful problem solver, I possess an innate ability to accept and navigate challenges, implement scientific troubleshooting methods, and communicate findings and opportunities internally and externally to technical and non-technical audiences. I thrive as an effective people leader with success achieving corporate targets, developing high performance teams, identifying issues, mitigating risks, and building client relationships driving business development and expanding existing opportunities.Career Highlights:* Built and grew team focused on oligonucleotides and nucleic-acid based therapeutics. Developed strategies to target new sponsors and expanded workstreams with existing sponsors. Expanded team from 10 to 38, added immunogenicity, and regulated biomarker analysis in addition to pharmacokinetic analysis. Increased revenue and external sponsors from 10 to 20+.* Expanded team operations to include Cell and Gene Therapy supporting 6 active sponsors. * Oversaw development of ~220 PK, ADA, and regulated biomarker methods and qualified or validated ~200 to support pre-clinical and clinical sample analysis in past 5-years. Led analysis supporting ~250 pre-clinical and clinical protocols. * Implementation of “Full Time Equivalency” model that allowed dedicated capacity in terms of man hours billed at monthly rate per set number of hours. * Participated on team that won first client in newly created Vaccine program. Awarded 4 assays initially to measure total and neutralizing antibody responses. Built client relationship and secured additional 6 assays. Grew program from 1 vaccine program with 4 assays to 2 programs with >20 assays in under 2-years.Specialties: Leadership & Team Building • Bioanalysis & Biopharmaceuticals • Assay Development & Validation • Large Molecule LBA / CBA Operations • LBA Method Validation • PK, ADA, & Regulated Biomarkers • Cell Biology & Biotechnology • Clinical & Pre-clinical Project Management • GLP & GCP Compliance